Xin Wang

Xin (David) Wang is a Scientist II at Labcorp since April 2023, specializing in Diagnostics and Drug Development within Variant Science. Prior to this role, Xin served as a Clinical Scientist II at Rady Children's Institute for Genomic Medicine from October 2021 to April 2023, overseeing clinical operations and launching the Gene Curation program. Experience also includes a position as a Clinical Genomic Scientist at Quest Diagnostics from March 2020 to October 2021, focusing on molecular diagnostic curation and project management. Additionally, Xin worked as a Senior Review Analyst at GeneDx and held postdoctoral research positions at Harvard Medical School, Massachusetts General Hospital, and UMass Medical School. Xin's academic background includes a Ph.D. in Biochemistry and Molecular Biology from Peking Union Medical College and an M.D. from China Medical University.